FDA Inspection 1167075 — Conopco, Inc

Conopco, Inc — FEI 1947127

The FDA completed an inspection of Conopco, Inc on Apr 6, 2022 in Jefferson City, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 6, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Jefferson City, MO (United States)